Literature DB >> 1234407

Nervous system involvement in systemic lupus erythematosus.

T Gibson, A R Myers.   

Abstract

In a retrospective analysis of 80 patients with systemic lupus erythematosus (SLE) seen over a 10-year period, 41 (51%) exhibited neurological manifestations. Nervous system involvement was characterized by a significantly greater involvement of black patients (P less than 0-02), a higher incidence of renal failure after the first appearance of neurological features (P less than 0-05), and a significantly worse 10-year survival rate (P less than 0-05). Specific neurological investigations were generally unhelpful in diagnosis. The finding of hypoglycorrhachia in 4 patients was striking and may have pathogenetic significance. The lack of a specific diagnostic test for central nervous system involvement may have hindered recognition of a cerebral abscess in one patient. Treatment with massive doses of corticosteroids was not obviously more effective than treatment with smaller doses. Autopsy findings showed scattered small cerebral infarcts but vasculitis was apparent in only one case.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1234407      PMCID: PMC1006571          DOI: 10.1136/ard.35.5.398

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  28 in total

1.  CARRIER TRANSPORT OF GLUCOSE BETWEEN BLOOD AND CEREBROSPINAL FLUID.

Authors:  R A FISHMAN
Journal:  Am J Physiol       Date:  1964-04

2.  RACIAL AND SOCIAL FACTORS IN SYSTEMIC LUPUS ERYTHEMATOSUS.

Authors:  M SIEGEL; M SEELENFREUND
Journal:  JAMA       Date:  1965-01-11       Impact factor: 56.272

3.  HYPOGLYCORRHACHIA WITH MENINGEAL CARCINOMATOSIS. REPORT OF TWO CASES.

Authors:  Y S KIM; J S RESNICK
Journal:  Ann Intern Med       Date:  1965-07       Impact factor: 25.391

4.  Neurologic signs and symptoms as early manifestations of systemic lupus erythematosus.

Authors:  R G SIEKERT; E C CLARK
Journal:  Neurology       Date:  1955-02       Impact factor: 9.910

5.  Clinical features of chorea associated with systemic lupus erythematosus.

Authors:  J O Lusins; P A Szilagyi
Journal:  Am J Med       Date:  1975-06       Impact factor: 4.965

6.  Central nervous system disease in systemic lupus erythematosus. Therapy and prognosis.

Authors:  J S Sergent; M D Lockshin; M S Klempner; B A Lipsky
Journal:  Am J Med       Date:  1975-05       Impact factor: 4.965

7.  Neurological manifestations of sarcoidosis.

Authors:  W C Wiederholt; R G Siekert
Journal:  Neurology       Date:  1965-12       Impact factor: 9.910

8.  Aseptic meningitis in systemic lupus erythematosus. Report of three cases.

Authors:  J J Canoso; A S Cohen
Journal:  Arthritis Rheum       Date:  1975 Jul-Aug

9.  Systemic lupus erythematosus. Contrasts and comparisons.

Authors:  J L Decker; A D Steinberg; M E Gershwin; W E Seaman; J H Klippel; P H Plotz; S A Paget
Journal:  Ann Intern Med       Date:  1975-03       Impact factor: 25.391

10.  The heart in systemic lupus erythematosus and the changes induced in it by corticosteroid therapy. A study of 36 necropsy patients.

Authors:  B H Bulkley; W C Roberts
Journal:  Am J Med       Date:  1975-02       Impact factor: 4.965

View more
  39 in total

Review 1.  [Differential diagnosis of chronic inflammatory diseases of the central nervous system. Cerebrospinal fluid diagnosis and immunological parameters].

Authors:  D Reske; H-F Petereit
Journal:  Nervenarzt       Date:  2004-10       Impact factor: 1.214

Review 2.  Attributing psychopathology to systemic lupus erythematosus: some methodological considerations.

Authors:  G L Iverson; L M McCracken
Journal:  Ann Rheum Dis       Date:  1992-01       Impact factor: 19.103

Review 3.  Immune mediated diseases and immune modulation in the neurocritical care unit.

Authors:  Gloria von Geldern; Thomas McPharlin; Kyra Becker
Journal:  Neurotherapeutics       Date:  2012-01       Impact factor: 7.620

4.  Lower-lobe shrinkage relative to total lung volume in collagen vascular diseases.

Authors:  M Watanabe; T Igishi; N Burioka; J Kurai; Y Fukuoka; K Kato; A Yamasaki; Y Hasegawa; R Okazaki; E Shimizu
Journal:  Radiol Med       Date:  2010-06-23       Impact factor: 3.469

Review 5.  The central nervous system in systemic lupus erythematosus.

Authors:  M A Khamashta; R Cervera; G R Hughes
Journal:  Rheumatol Int       Date:  1991       Impact factor: 2.631

6.  The differential diagnosis of hypoglycorrhachia in adult patients.

Authors:  Eric Chow; Stephanie B Troy
Journal:  Am J Med Sci       Date:  2014-09       Impact factor: 2.378

7.  Systemic lupus erythematosus presenting as catatonic schizophrenia.

Authors:  M Tishler; A L Abramov
Journal:  Clin Rheumatol       Date:  1985-09       Impact factor: 2.980

Review 8.  Acute transverse myelopathy complicating systemic lupus erythematosus.

Authors:  D J Propper; R C Bucknall
Journal:  Ann Rheum Dis       Date:  1989-06       Impact factor: 19.103

9.  The pathogenesis of neuropsychiatric lupus.

Authors:  J A Denburg; P Temesvari
Journal:  Can Med Assoc J       Date:  1983-02-01       Impact factor: 8.262

Review 10.  Systemic lupus erythematosus (SLE)-like syndromes associated with carbamazepine therapy.

Authors:  K K Jain
Journal:  Drug Saf       Date:  1991 Sep-Oct       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.